-+ 0.00%
-+ 0.00%
-+ 0.00%

Spruce Biosciences names Eric Jordan as VP, Marketing

PUBT·06/15/2026 12:01:41
Listen to the news
Spruce Biosciences names Eric Jordan as VP, Marketing
  • Spruce Biosciences named Eric Jordan vice president, marketing, as it prepares for a potential U.S. FDA approval and launch of TA-ERT.
  • Jordan previously led marketing and launch planning for encaleret at BridgeBio.
  • He earlier ran U.S. commercialization of Oxervate at Dompé Pharmaceuticals, helping build it into a $1 billion brand.
  • Tina Gullotta joined as vice president, finance, corporate controller, tasked with scaling finance and reporting as Spruce moves toward commercialization.
  • Gullotta was vice president, finance at Frontier Medicines, following senior finance roles at Sunesis Pharmaceuticals and Atara Biotherapeutics.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spruce Biosciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260615126975) on June 15, 2026, and is solely responsible for the information contained therein.